Discovery of shear- and side-specific mRNAs and miRNAs in human aortic valvular endothelial cells.

The role of endothelial cells (ECs) in aortic valve (AV) disease remains relatively unknown; however, disease preferentially occurs in the fibrosa. We hypothesized oscillatory shear (OS) present on the fibrosa stimulates ECs to modify mRNAs and microRNAs (miRNAs) inducing disease. Our goal was to identify mRNAs and miRNAs differentially regulated by OS and laminar shear (LS) in human AVECs (HAVECs) from the fibrosa (fHAVECs) and ventricularis (vHAVECs). HAVECs expressed EC markers as well as some smooth muscle cell markers and functionally aligned with the flow. HAVECs were exposed to OS and LS for 24 h, and total RNA was analyzed by mRNA and miRNA microarrays. We found over 700 and 300 mRNAs down- and upregulated, respectively, by OS; however, there was no side dependency. mRNA microarray results were validated for 26 of 28 tested genes. Ingenuity Pathway Analysis revealed thrombospondin 1 (Thbs1) and NF-κB inhibitor-α (Nfkbia) as highly connected, shear-sensitive genes. miRNA array analysis yielded 30 shear-sensitive miRNAs and 3 side-specific miRNAs. miRNA validation confirmed 4 of 17 shear-sensitive miRNAs and 1 of 3 side-dependent miRNAs. Using miRWalk and several filtering steps, we identified shear-sensitive mRNAs potentially targeted by shear-sensitive miRNAs. These genes and signaling pathways could act as therapeutic targets of AV disease.

[1]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.

[2]  R. Kalluri,et al.  Conversion of vascular endothelial cells into multipotent stem-like cells , 2010, Nature Medicine.

[3]  W. Schaper,et al.  Cardiac microvascular endothelial cells express α-smooth muscle actin and show low NOS III activity. , 1999, American journal of physiology. Heart and circulatory physiology.

[4]  O. Volpert,et al.  Thrombospondin and apoptosis: molecular mechanisms and use for design of complementation treatments. , 2008, Current drug targets.

[5]  A. Tajik,et al.  Human Aortic Valve Calcification Is Associated With an Osteoblast Phenotype , 2003, Circulation.

[6]  M. Byrom,et al.  Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis , 2005, Nucleic acids research.

[7]  E. Mohler.  Mechanisms of aortic valve calcification. , 2004, The American journal of cardiology.

[8]  M. Lindsay,et al.  Expression profiling in vivo demonstrates rapid changes in lung microRNA levels following lipopolysaccharide-induced inflammation but not in the anti-inflammatory action of glucocorticoids , 2007, BMC Genomics.

[9]  Nicholas T. Ingolia,et al.  Mammalian microRNAs predominantly act to decrease target mRNA levels , 2010, Nature.

[10]  S. Hagl,et al.  Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis. , 2003, Atherosclerosis.

[11]  M. Mäyränpää,et al.  Induction of local angiotensin II-producing systems in stenotic aortic valves. , 2004, Journal of the American College of Cardiology.

[12]  A. Gown,et al.  Characterization of the Early Lesion of ‘Degenerative’ Valvular Aortic Stenosis: Histological and Immunohistochemical Studies , 1994, Circulation.

[13]  Y. Bossé,et al.  Refining Molecular Pathways Leading to Calcific Aortic Valve Stenosis by Studying Gene Expression Profile of Normal and Calcified Stenotic Human Aortic Valves , 2009, Circulation. Cardiovascular genetics.

[14]  K. Schmid,et al.  Differential expression of microRNA-675, microRNA-139-3p and microRNA-335 in benign and malignant adrenocortical tumours , 2011, Journal of Clinical Pathology.

[15]  A. Ishisaki,et al.  Human Umbilical Vein Endothelium-derived Cells Retain Potential to Differentiate into Smooth Muscle-like Cells* , 2003, The Journal of Biological Chemistry.

[16]  E. Olson,et al.  Toward microRNA-based therapeutics for heart disease: the sense in antisense. , 2008, Circulation research.

[17]  H. Jo,et al.  MicroRNA-663 upregulated by oscillatory shear stress plays a role in inflammatory response of endothelial cells. , 2011, American journal of physiology. Heart and circulatory physiology.

[18]  D. Srivastava,et al.  Altered microRNAs in bicuspid aortic valve: a comparison between stenotic and insufficient valves. , 2010, The Journal of heart valve disease.

[19]  Eli J. Weinberg,et al.  Hemodynamic Environments from Opposing Sides of Human Aortic Valve Leaflets Evoke Distinct Endothelial Phenotypes In Vitro , 2010, Cardiovascular engineering.

[20]  P. Igaz,et al.  MicroRNA expression profiling in benign (sporadic and hereditary) and recurring adrenal pheochromocytomas , 2010, Modern Pathology.

[21]  F. Schoen,et al.  Aortic Valve Endothelial Cells Undergo Transforming Growth Factor-β-Mediated and Non-Transforming Growth Factor-β-Mediated Transdifferentiation in Vitro , 2001 .

[22]  H. Jo,et al.  Laminar Shear Stress Up-regulates Peroxiredoxins (PRX) in Endothelial Cells , 2008, Journal of Biological Chemistry.

[23]  Y. Bossé,et al.  Genomics: the next step to elucidate the etiology of calcific aortic valve stenosis. , 2008, Journal of the American College of Cardiology.

[24]  Ajit P Yoganathan,et al.  Altered Shear Stress Stimulates Upregulation of Endothelial VCAM-1 and ICAM-1 in a BMP-4– and TGF-&bgr;1–Dependent Pathway , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[25]  G. Tseng,et al.  MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. , 2008, The Journal of clinical endocrinology and metabolism.

[26]  M. Hanson,et al.  Maternal high fat diet during pregnancy and lactation alters hepatic expression of insulin like growth factor-2 and key microRNAs in the adult offspring , 2009, BMC Genomics.

[27]  R M Nerem,et al.  The elongation and orientation of cultured endothelial cells in response to shear stress. , 1985, Journal of biomechanical engineering.

[28]  G. Novo,et al.  Atherosclerosis, degenerative aortic stenosis and statins. , 2011, Current drug targets.

[29]  G. Thiene,et al.  Pathology and pathogenesis of infective endocarditis in native heart valves. , 2006, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[30]  K. Mann,et al.  Inhibition of Liver X Receptor/Retinoid X Receptor–Mediated Transcription Contributes to the Proatherogenic Effects of Arsenic in Macrophages In Vitro , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[31]  C. Otto,et al.  Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[32]  J. Visvader,et al.  Discovery of novel mechanosensitive genes in vivo using mouse carotid artery endothelium exposed to disturbed flow. , 2010, Blood.

[33]  Robert M Nerem,et al.  Unique Morphology and Focal Adhesion Development of Valvular Endothelial Cells in Static and Fluid Flow Environments , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[34]  Israel Steinfeld,et al.  Novel Rank-Based Statistical Methods Reveal MicroRNAs with Differential Expression in Multiple Cancer Types , 2009, PloS one.

[35]  Xiaoying Shen,et al.  MicroRNA expression profiles in human colorectal cancers with liver metastases. , 2011, Oncology reports.

[36]  M. Papadaki,et al.  Effects of Fluid Shear Stress on Gene Regulation of Vascular Cells , 1997, Biotechnology progress.

[37]  Q. Cui,et al.  MicroRNA-19a mediates the suppressive effect of laminar flow on cyclin D1 expression in human umbilical vein endothelial cells , 2010, Proceedings of the National Academy of Sciences.

[38]  E. Oliva,et al.  Micro‐RNA signature of the epithelial–mesenchymal transition in endometrial carcinosarcoma , 2011, The Journal of pathology.

[39]  M. Civelek,et al.  MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro , 2010, Proceedings of the National Academy of Sciences.

[40]  I. Holme,et al.  Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study. , 2007, The American journal of cardiology.

[41]  Craig A. Simmons,et al.  Spatial Heterogeneity of Endothelial Phenotypes Correlates With Side-Specific Vulnerability to Calcification in Normal Porcine Aortic Valves , 2005, Circulation research.

[42]  S. Hagl,et al.  Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis. , 2005, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[43]  Bo Song,et al.  miR-192 Regulates Dihydrofolate Reductase and Cellular Proliferation through the p53-microRNA Circuit , 2008, Clinical Cancer Research.

[44]  K. Teo,et al.  Effect of Lipid Lowering With Rosuvastatin on Progression of Aortic Stenosis: Results of the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) Trial , 2010, Circulation.

[45]  JanNilsson,et al.  Presence of Oxidized Low Density Lipoprotein in Nonrheumatic Stenotic Aortic Valves , 1999 .

[46]  C. Otto,et al.  Valvular aortic stenosis: disease severity and timing of intervention. , 2006, Journal of the American College of Cardiology.

[47]  G. Stark,et al.  NFκB-dependent signaling pathways , 2002 .

[48]  Ajit P. Yoganathan,et al.  Altered Shear Stress Stimulates Upregulation of Endothelial VCAM-1 and ICAM-1 in a BMP-4- and TGF-β1-Dependent Pathway , 2009 .

[49]  Larry V McIntire,et al.  Endothelial cell responses to atheroprone flow are driven by two separate flow components: low time-average shear stress and fluid flow reversal. , 2010, American journal of physiology. Heart and circulatory physiology.

[50]  Junjie Xiao,et al.  Circulating microRNAs: novel biomarkers for cardiovascular diseases , 2011, Journal of Molecular Medicine.

[51]  Aimee L Jackson,et al.  Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215. , 2008, Cancer research.

[52]  W. Roberts,et al.  Frequency by Decades of Unicuspid, Bicuspid, and Tricuspid Aortic Valves in Adults Having Isolated Aortic Valve Replacement for Aortic Stenosis, With or Without Associated Aortic Regurgitation , 2005, Circulation.

[53]  S. Subramaniam,et al.  Role of microRNA-23b in flow-regulation of Rb phosphorylation and endothelial cell growth , 2010, Proceedings of the National Academy of Sciences.

[54]  A. Abbate,et al.  Phosphodiesterase-5 Inhibitor, Tadalafil, Protects Against Myocardial Ischemia/Reperfusion Through Protein-Kinase G–Dependent Generation of Hydrogen Sulfide , 2009, Circulation.